1. P334 Effectiveness and safety of ustekinumab in Crohn's disease: short and long-term results of a multi-refractory cohort. (21st January 2022) Authors: Aparicio-Serrano, A; Zamora Olaya, J M; Ortiz Chimbo, D S; Rodríguez Tirado, M I; Gómez Pérez, A; Soto Escribano, P; Marín Pedrosa, S; Iglesias Flores, E; Benítez, J M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P410 Safety of biological drugs for inflammatory bowel disease in elderly patients. (21st January 2022) Authors: Suarez Ferrer, C J; Mesonero, F; Caballol, B; Ballester, M P; Baston Rey, I; Castaño Garcia, A; Miranda Bautista, J; Saiz Chumillas, R; Benitez, J M; Sanchez Delgado, L; Lopez-Garcia, A; Rubin de Celix, C; Lopez Sanroma, A; Martin-Arranz, M D; Fernández-Clotet, A; Merino Murgui, V; Calviño Suárez... Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P507 Need for surgery in patients with ulcerative colitis in the era of biologic therapy. (21st January 2022) Authors: Zamora Olaya, J M; Aparicio-Serrano, A; Gómez Pérez, A; Ortiz Chimbo, D S; Rodríguez Tirado, M I; Soto Escribano, P; Marín Pedrosa, S; Iglesias Flores, E; Benítez, J M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P523 Effectiveness of biological treatments for inflammatory bowel disease in the elderly patients. (21st January 2022) Authors: Suarez Ferrer, C J; Mesonero, F; Caballol, B; Ballester, M P; Baston Rey, I; Castaño Garcia, A; Miranda Bautista, J; Saiz Chumillas, R; Benitez, J M; Sanchez Delgado, L; Lopez-Garcia, A; Rubin de Celix, C; Martin-Arranz, M D; Lopez Sanroman, A; Fernandez-Clotet, A; Merino Murgui, V; Calviño Suare... Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P534 Effectiveness and safety of Adalimumab switch from originator to biosimilar in patients with inflammatory bowel disease in clinical remission. (21st January 2022) Authors: Gros, B; Soto Escribano, P; Marín Pedrosa, S; Medina Medina, R; Benítez, J M; Iglesias-Flores, E Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗